Alvin Shih's Net Worth

$3.43 Million

Estimate Recalculated Nov 1, 2024 11:37AM EST

Who is Alvin Shih

Alvin Shih has an estimated net worth of $3.43 Million. This is based on reported shares across multiple companies, which include ZEVRA THERAPEUTICS, INC., and Retrophin, Inc..

SEC CIK

Alvin Shih's CIK is 0001610064

Past Insider Trading and Trends

2024 was Alvin Shih's most active year for acquiring shares with 2 total transactions. Alvin Shih's most active month to acquire stocks was the month of April. 2015 was Alvin Shih's most active year for disposing of shares, totalling 5 transactions. Alvin Shih's most active month to dispose stocks was the month of September. 2015 saw Alvin Shih paying a total of $0.00 for 60,000 shares, this is the most they've acquired in one year. In 2015 Alvin Shih cashed out on 45,416 shares for a total of $1,271,185.79, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZEVRA THERAPEUTICS, INC.

Investor
Updated May 15, 2024
Form 4
39.20K
May 15, 2024
39.20K
Grant
May 13
Form 4
58.80K
Feb 02, 2024
58.80K
Grant
Jan 20
Form 3
Feb 02, 2024
Showing 3 results

Retrophin, Inc.

EVP Research & Development
Updated Sep 02, 2016
Form 4
-5.24%
-8.75K
$16.24
-$142.06K
Sep 02, 2016
158.33K
Sale
ScheduledSep 01
Form 4
-4.98%
-8.75K
$17.75
-$155.28K
Jun 02, 2016
167.08K
Sale
ScheduledJun 01
Form 4
60.00K
May 23, 2016
60.00K
Grant
May 19
Form 4
-4.74%
-8.75K
$14.35
-$125.57K
Mar 01, 2016
175.83K
Sale
ScheduledMar 01
Form 4
-4.53%
-8.75K
$20.83
-$182.26K
Dec 10, 2015
184.58K
Sale
ScheduledDec 09
Form 4
-4.33%
-8.75K
$20.12
-$176.07K
Oct 08, 2015
193.33K
Sale
ScheduledOct 06
Form 4
60.00K
Jul 02, 2015
60.00K
Grant
Jul 01
Form 4
-12.14%
-27.92K
$32.70
-$912.85K
Jun 30, 2015
202.08K
Sale
ScheduledJun 26
Form 3
Jun 11, 2014
230.00K
Showing 9 results

Oaktree Acquisition Corp. III Life Sciences

Investor
Updated Oct 23, 2024
Form 3
Oct 23, 2024
Showing 1 results